Vanthida Huang

936 total citations
34 papers, 702 citations indexed

About

Vanthida Huang is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Vanthida Huang has authored 34 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Pharmacology and 12 papers in Clinical Biochemistry. Recurrent topics in Vanthida Huang's work include Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Vanthida Huang is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Vanthida Huang collaborates with scholars based in United States, Switzerland and Netherlands. Vanthida Huang's co-authors include Michael J. Rybak, Kyle C. Molina, Marcus Zervos, Daniela Sales Alviano, Mary Beth Perri, Pamela Hartman, Jon Hiles, Melvin P. Weinstein, Tiffany E. Bias and Jason C Gallagher and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Vanthida Huang

32 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanthida Huang United States	15	325	239	177	170	154	34	702
Luis Eduardo López-Cortés Spain	17	419 1.3×	222 0.9×	96 0.5×	278 1.6×	214 1.4×	61	810
Guilherme Henrique Campos Furtado Brazil	17	227 0.7×	153 0.6×	221 1.2×	201 1.2×	122 0.8×	40	652
Daisuke Sakanashi Japan	17	287 0.9×	110 0.5×	166 0.9×	368 2.2×	104 0.7×	86	873
Jamie L. Wagner United States	14	166 0.5×	195 0.8×	185 1.0×	204 1.2×	104 0.7×	74	709
M L van Ogtrop Netherlands	14	341 1.0×	381 1.6×	335 1.9×	274 1.6×	162 1.1×	20	981
Grace C. Lee United States	17	339 1.0×	152 0.6×	271 1.5×	328 1.9×	167 1.1×	41	1.1k
Shellee A. Grim United States	18	420 1.3×	204 0.9×	169 1.0×	423 2.5×	83 0.5×	35	1.1k
Daniel Havlichek United States	15	212 0.7×	180 0.8×	120 0.7×	226 1.3×	71 0.5×	42	650
Purvi Mehra United States	8	520 1.6×	289 1.2×	142 0.8×	114 0.7×	322 2.1×	13	780
Alessio Mesini Italy	13	339 1.0×	147 0.6×	101 0.6×	280 1.6×	148 1.0×	49	662

Countries citing papers authored by Vanthida Huang

Since Specialization

Citations

This map shows the geographic impact of Vanthida Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanthida Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanthida Huang more than expected).

Fields of papers citing papers by Vanthida Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanthida Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanthida Huang. The network helps show where Vanthida Huang may publish in the future.

Co-authorship network of co-authors of Vanthida Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Vanthida Huang. A scholar is included among the top collaborators of Vanthida Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanthida Huang. Vanthida Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harris, S. T. & Vanthida Huang. (2025). P-1531. Two against One: Ceftazidime-Avibactam plus Aztreonam vs Cefiderocol in the Treatment of Metallo-Beta-Lactamase-Producing Bacterial Infections. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Barletta, Jeffrey F., et al.. (2023). 726. Risk factor analysis for cefepime and piperacillin/tazobactam resistant organisms. Open Forum Infectious Diseases. 10(Supplement_2).

Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2021). Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open Forum Infectious Diseases. 9(3). ofab606–ofab606. 18 indexed citations

Molina, Kyle C., Taylor Morrisette, Matthew A. Miller, Vanthida Huang, & Douglas N. Fish. (2020). The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 64(7). 23 indexed citations

Huang, Vanthida, et al.. (2019). Antibiotic Hypersensitivity Mechanisms. SHILAP Revista de lepidopterología. 7(3). 122–122. 29 indexed citations

Molina, Kyle C., et al.. (2019). Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal Clearance. Surgical Infections. 21(1). 43–47. 8 indexed citations

Arshad, Samia, Vanthida Huang, Pamela Hartman, et al.. (2017). Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study. International Journal of Infectious Diseases. 57. 27–31. 43 indexed citations

Bardossy, Ana C., Ricardo Ortíz, Daniela Sales Alviano, et al.. (2017). Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. International Journal of Infectious Diseases. 61. 3–6. 22 indexed citations

Lodise, Thomas P., Manjunath P. Pai, Marina Rabinovich, et al.. (2016). Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis. Surgical Infections. 17(6). 675–682. 2 indexed citations

10.

Huang, Vanthida, et al.. (2016). Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE). Current Infectious Disease Reports. 18(12). 48–48. 15 indexed citations

11.

Molina, Kyle C. & Vanthida Huang. (2016). Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections. Current Infectious Disease Reports. 18(12). 47–47. 7 indexed citations

12.

Huang, Vanthida, Michael E. Klepser, Paul O. Gubbins, et al.. (2015). Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharmacy Education. 15(1). 1–6. 4 indexed citations

13.

Quinn, Margaret, Paul K. Henneberger, Barbara I. Braun, et al.. (2015). Cleaning and disinfecting environmental surfaces in health care: Toward an integrated framework for infection and occupational illness prevention. American Journal of Infection Control. 43(5). 424–434. 130 indexed citations

14.

Cho, Jonathan C., et al.. (2015). Neisseria gonorrhoeae and fosfomycin: Past, present and future. International Journal of Antimicrobial Agents. 46(3). 290–296. 13 indexed citations

15.

Alviano, Daniela Sales, Samia Arshad, Mary Beth Perri, et al.. (2014). Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infections. Journal of Global Antimicrobial Resistance. 2(4). 280–285. 1 indexed citations

16.

Ngo, Dung, et al.. (2011). Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus. BMC Infectious Diseases. 11(1). 287–287. 28 indexed citations

17.

Tenover, Fred C., et al.. (2009). Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. International Journal of Antimicrobial Agents. 33(6). 564–568. 54 indexed citations

18.

Huang, Vanthida, Chrissy M. Cheung, Glenn W. Kaatz, & Michael J. Rybak. (2009). Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 35(1). 25–29. 14 indexed citations

19.

Huang, Vanthida, et al.. (2006). Risk of Serotonin Syndrome with Concomitant Administration of Linezolid and Serotonin Agonists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(12). 1784–1793. 51 indexed citations

20.

Huang, Vanthida & Michael J. Rybak. (2005). Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function. Journal of Antimicrobial Chemotherapy. 57(1). 116–121. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact